- Home
- SBFM vs ACON Comparison
SBFM vs ACON Comparison
Compare SBFM & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- ACON
- Stock Information
- Founded
- SBFM 2006
- ACON 2008
- Country
- SBFM United States
- ACON United States
- Employees
- SBFM N/A
- ACON N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- SBFM Health Care
- ACON Technology
- Exchange
- SBFM Nasdaq
- ACON Nasdaq
- Market Cap
- SBFM 4.9M
- ACON 4.8M
- IPO Year
- SBFM N/A
- ACON 2022
- Fundamental
- Price
- SBFM $1.55
- ACON $7.64
- Analyst Decision
- SBFM Strong Buy
- ACON Buy
- Analyst Count
- SBFM 1
- ACON 2
- Target Price
- SBFM $15.00
- ACON $481.00
- AVG Volume (30 Days)
- SBFM 4.3M
- ACON 75.1K
- Earning Date
- SBFM 05-19-2025
- ACON 04-09-2025
- Dividend Yield
- SBFM N/A
- ACON N/A
- EPS Growth
- SBFM N/A
- ACON N/A
- EPS
- SBFM N/A
- ACON N/A
- Revenue
- SBFM $34,874,283.00
- ACON $45,724.00
- Revenue This Year
- SBFM $192.48
- ACON $251.35
- Revenue Next Year
- SBFM N/A
- ACON N/A
- P/E Ratio
- SBFM N/A
- ACON N/A
- Revenue Growth
- SBFM 44.75
- ACON N/A
- 52 Week Low
- SBFM $1.17
- ACON $7.26
- 52 Week High
- SBFM $33.60
- ACON $6,241.05
- Technical
- Relative Strength Index (RSI)
- SBFM 44.81
- ACON 33.40
- Support Level
- SBFM $1.17
- ACON $8.15
- Resistance Level
- SBFM $1.59
- ACON $8.30
- Average True Range (ATR)
- SBFM 0.19
- ACON 1.25
- MACD
- SBFM 0.03
- ACON 6.41
- Stochastic Oscillator
- SBFM 52.84
- ACON 6.94
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.